+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Actinic Keratosis Treatment Market by Treatment Mechanism, Drug Class, End User, Distribution Channel - Global Forecast to 2030- Product Image
Actinic Keratosis Treatment Market by Treatment Mechanism, Drug Class, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Actinic Keratosis Treatment Market by Treatment Mechanism, Drug Class, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716164
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The actinic keratosis treatment market is evolving rapidly as healthcare systems adapt to changing patient demographics, regulatory environments, and clinical needs. Driven by innovation and expanding access, the sector is shaped by emerging therapeutic modalities and shifting stakeholder priorities.

Market Snapshot: Actinic Keratosis Treatment Market Growth

The Actinic Keratosis Treatment Market grew from USD 6.48 billion in 2024 to USD 6.77 billion in 2025. It is expected to continue growing at a CAGR of 4.38%, reaching USD 8.39 billion by 2030. Market growth is underpinned by an aging global population, higher ultraviolet exposure, and widening adoption of both procedural and pharmacologic therapies. Stakeholders from healthcare providers to payers are reevaluating their strategies as new treatment options and digital innovations gain ground. The competitive landscape is marked by advancements in laser, photodynamic, and digital care approaches, offering stakeholders multifaceted opportunities across regions.

Scope & Segmentation

  • Treatment Mechanisms: Chemical peels, cryotherapy, laser therapy, pharmacotherapy (over-the-counter and prescription drugs including diclofenac, fluorouracil, imiquimod, ingenol mebutate), and photodynamic therapy.
  • Drug Classes: Diclofenac, fluorouracil, imiquimod, ingenol mebutate.
  • End Users: Clinics, home care, hospitals.
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy.
  • Geographic Coverage: Americas (notably the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, UAE, South Africa, and more), Asia-Pacific (such as China, Japan, Australia, India, South Korea, and additional markets).
  • Company Coverage: Companies analyzed include Galderma S.A., LEO Pharma A/S, Bausch Health Companies Inc., Almirall S.A., Basilea Pharmaceutica International Ltd., Biofrontera AG, Photocure ASA, Verrica Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., and Viatris Inc.
  • Technologies: Innovations span laser devices, light-emitting diode systems, topical agents, digital diagnostics, and teledermatology platforms.

Key Takeaways

  • Adoption of novel laser therapies and photodynamic approaches continues to reshape clinical protocols, offering enhanced precision with minimal patient downtime.
  • Refinements in topical pharmacotherapies, including improved tolerability profiles, support at-home treatment for milder lesions and augment patient convenience.
  • Strategic alliances between pharmaceutical firms and device manufacturers are accelerating combination protocols, enabling integrated care models that address varying patient and clinical needs.
  • The expansion of digital diagnostic tools and teledermatology platforms enhances early detection and remote monitoring, broadening access—especially in underserved and geographically diverse markets.
  • Market segmentation underscores a growing preference for personalized medicine, with treatment regimens tailored according to disease severity, patient skin type, and comorbidity profiles.
  • Home-based care continues to expand, accelerated by user-friendly formulations and consumer demand for cost-effective solutions outside traditional clinical settings.

Tariff Impact on U.S. Market

In the United States, recently imposed import tariffs on active pharmaceutical ingredients and specialized device components have introduced cost pressures for manufacturers reliant on global suppliers. Increased production expenses are challenging existing procurement and reimbursement models for both drug-based and device-based therapies. Companies are considering nearshoring strategies and engaging policymakers to mitigate the potential for supply chain disruptions and preserve equitable patient access to necessary dermatological treatments.

Methodology & Data Sources

Research methodology combined primary interviews with dermatologists, industry executives, and supply chain specialists, with comprehensive secondary research from peer-reviewed literature, regulatory filings, and market intelligence databases. Quantitative and qualitative analyses assessed competitive landscape, pricing, and strategic trends. Rigorous data verification protocols and subject matter review underpinned report accuracy and objectivity.

Why This Report Matters

  • Equips decision-makers with actionable insights into evolving technologies, policy landscapes, and market dynamics specific to actinic keratosis care.
  • Enables strategic planning based on robust segmentation, regional detail, and competitive profiling of leading and emerging market players.
  • Supports risk mitigation by highlighting the implications of regulatory shifts and global supply chain developments on treatment availability.

Conclusion

Senior stakeholders can leverage these findings to drive informed investments and resilient strategies in actinic keratosis treatment. Comprehensive segmentation, regional perspectives, and technology trends offer a platform for capitalizing on market opportunities and safeguarding patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Actinic Keratosis Treatment Market, by Treatment Mechanism
8.1. Introduction
8.2. Chemical Peels
8.3. Cryotherapy
8.4. Laser Therapy
8.5. Pharmacotherapy
8.5.1. Over-The-Counter Drugs
8.5.1.1. Diclofenac
8.5.2. Prescription Drugs
8.5.2.1. Diclofenac
8.5.2.2. Fluorouracil
8.5.2.3. Imiquimod
8.5.2.4. Ingenol Mebutate
8.6. Photodynamic Therapy
9. Actinic Keratosis Treatment Market, by Drug Class
9.1. Introduction
9.2. Diclofenac
9.3. Fluorouracil
9.4. Imiquimod
9.5. Ingenol Mebutate
10. Actinic Keratosis Treatment Market, by End User
10.1. Introduction
10.2. Clinic
10.3. Home Care
10.4. Hospital
11. Actinic Keratosis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Americas Actinic Keratosis Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Actinic Keratosis Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Actinic Keratosis Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Galderma S.A.
15.3.2. LEO Pharma A/S
15.3.3. Bausch Health Companies Inc.
15.3.4. Almirall, S.A.
15.3.5. Basilea Pharmaceutica International Ltd.
15.3.6. Biofrontera AG
15.3.7. Photocure ASA
15.3.8. Verrica Pharmaceuticals, Inc.
15.3.9. Sun Pharmaceutical Industries Ltd.
15.3.10. Viatris Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ACTINIC KERATOSIS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. ACTINIC KERATOSIS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. ACTINIC KERATOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ACTINIC KERATOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ACTINIC KERATOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ACTINIC KERATOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CRYOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY FLUOROURACIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY IMIQUIMOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY INGENOL MEBUTATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY FLUOROURACIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY IMIQUIMOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY INGENOL MEBUTATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 52. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 53. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 54. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 55. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 56. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 60. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 63. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED KINGDOM ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 95. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. GERMANY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 102. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 103. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 104. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 105. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. FRANCE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 116. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 117. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 118. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 119. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 120. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. ITALY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 123. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 124. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 125. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 126. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. SAUDI ARABIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 149. SOUTH AFRICA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 151. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. DENMARK ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 165. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 166. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 167. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 168. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 169. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. QATAR ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 172. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 173. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 174. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 175. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 176. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. FINLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. SWEDEN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 193. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 194. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 195. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 196. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 197. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. EGYPT ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 200. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 201. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 202. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 203. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 204. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. TURKEY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 214. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 215. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 216. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 217. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 218. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. NORWAY ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 221. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 222. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 223. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 224. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 225. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. POLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 242. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 243. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 244. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 245. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 246. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 247. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 248. CHINA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 250. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 251. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 252. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 253. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 254. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. INDIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 257. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 258. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 259. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 260. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 261. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. JAPAN ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. INDONESIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 285. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 286. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 287. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 289. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. THAILAND ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. PHILIPPINES ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY TREATMENT MECHANISM, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER DRUGS, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE ACTINIC KERATOSIS TREATMENT MARKET S

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Actinic Keratosis Treatment market report include:
  • Galderma S.A.
  • LEO Pharma A/S
  • Bausch Health Companies Inc.
  • Almirall, S.A.
  • Basilea Pharmaceutica International Ltd.
  • Biofrontera AG
  • Photocure ASA
  • Verrica Pharmaceuticals, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.77 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.39 Billion
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class (NSAIDs), By End use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Actinic Keratosis Treatment Market Size, Share & Trends Analysis Report By Therapy (Topical, Surgery, Photodynamic Therapy), By Drug Class (NSAIDs), By End use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 100 Pages
  • Global
From
Actinic Keratosis Treatment Market Report by Type, Drug Type, Distribution Channel, and Region 2024-2032 - Product Image

Actinic Keratosis Treatment Market Report by Type, Drug Type, Distribution Channel, and Region 2024-2032

  • Report
  • 136 Pages
  • Global
From
Actinic Keratosis Treatment Market Report 2025 - Product Image

Actinic Keratosis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Actinic Keratosis Treatment - Global Strategic Business Report - Product Image

Actinic Keratosis Treatment - Global Strategic Business Report

  • Report
  • 354 Pages
  • Global
From
Actinic Keratosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Actinic Keratosis Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From

About the Actinic Keratosis Drug Market

Actinic Keratosis (AK) is a pre-cancerous skin condition caused by long-term exposure to ultraviolet (UV) radiation. It is characterized by scaly, rough patches on the skin that can become cancerous if left untreated. Skin cancer drugs are used to treat AK and prevent it from progressing to a more serious form of skin cancer. These drugs are typically topical creams or ointments that are applied directly to the affected area. They work by slowing down the growth of abnormal cells and preventing them from spreading. The Actinic Keratosis Drug market is a subset of the larger Skin Cancer Drug market. It is composed of a variety of products, including topical creams, ointments, and other treatments. These products are used to treat AK and prevent it from progressing to a more serious form of skin cancer. Some companies in the Actinic Keratosis Drug market include Galderma, Leo Pharma, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.